These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13901404)

  • 1. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H; ERICKSON RW
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():407-25. PubMed ID: 13901404
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action on behavior of the combination of tranylcypromine and reserpine].
    BABBINI M; RICCIONI ML; MISSERE G; TONINI G
    Arch Ital Sci Farmacol; 1961 Oct; 11():310-2. PubMed ID: 13863628
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropharmacology of tranylcypromine and trifluoperazine.
    TEDESCHI RE; TEDESCHI DH; FELLOWS EJ
    Can Psychiatr Assoc J; 1962; 7(Suppl)():55-9. PubMed ID: 13920073
    [No Abstract]   [Full Text] [Related]  

  • 5. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM
    Can Psychiatr Assoc J; 1962; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N; MAFFEI-FACCIOLI A
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of monoamine oxidase inhibitors and reserpine on the gamma-aminobutyric acid content of the rat brain].
    Popov N; Matthies HJ
    Acta Biol Med Ger; 1967; 18(1):91-8. PubMed ID: 5587220
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.
    GREEN H; ERICKSON RW
    J Pharmacol Exp Ther; 1960 Jul; 129():237-42. PubMed ID: 13851486
    [No Abstract]   [Full Text] [Related]  

  • 9. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
    LEMERE F
    Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of reserpine and monoamine oxidase inhibitors on the urinary excretion of catecholamines in the rat.
    BICKEL MH; CARPI A; BOVET D
    Helv Physiol Pharmacol Acta; 1961; 19():279-84. PubMed ID: 13868969
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of reserpine and monoamine oxidase inhibitors on paradoxical sleep in the monkey.
    Reite M; Pegram GV; Stephens LM; Bixler EC; Lewis OL
    Psychopharmacologia; 1969; 14(1):12-7. PubMed ID: 4310917
    [No Abstract]   [Full Text] [Related]  

  • 13. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase.
    TEDESCHI RE; TEDESCHI DH; AMES PL; COOK L; MATTIS PA; FELLOWS EJ
    Proc Soc Exp Biol Med; 1959 Nov; 102():380-1. PubMed ID: 13837261
    [No Abstract]   [Full Text] [Related]  

  • 14. Tranylcypromine on fifty ambulatory psychiatric patients.
    DARLING HF
    Dis Nerv Syst; 1962 Feb; 23():91-2. PubMed ID: 13883578
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A; Serrano JS; Jané F; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranylcypromine and the extrapyramidal syndromes.
    BARBEAU A; DUCHASTEL Y
    Can Psychiatr Assoc J; 1962; 7(Suppl)():91-5. PubMed ID: 13864822
    [No Abstract]   [Full Text] [Related]  

  • 17. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S
    Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors.
    Greeff K; Dènes B; Tawfik H
    Mod Probl Pharmacopsychiatry; 1983; 19():220-30. PubMed ID: 6408408
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
    BRAM G
    Can Psychiatr Assoc J; 1962; 7(Suppl)():84-6. PubMed ID: 13872435
    [No Abstract]   [Full Text] [Related]  

  • 20. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT; JACK D; SPENCER PS
    J Pharm Pharmacol; 1964 Aug; 16():565-7. PubMed ID: 14223999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.